Sentence: The B-cell lymphoma 2 ( BCL-2 ) inhibitor venetoclax has an emerging role in acute myeloid leukemia ( AML ) , with promising response rates in combination with hypomethylating agents or low-dose cytarabine in older patients .
Drug combination annotation:
[{'class': 'POS', 'spans': ['venetoclax', 'cytarabine'], 'is_context_needed': False}]